IN2014MN02418A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02418A IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
- Authority
- IN
- India
- Prior art keywords
- methods
- breast cancer
- subject
- gene expression
- evaluating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650209P | 2012-05-22 | 2012-05-22 | |
| US201361753673P | 2013-01-17 | 2013-01-17 | |
| PCT/US2013/042157 WO2013177245A2 (en) | 2012-05-22 | 2013-05-22 | Nano46 genes and methods to predict breast cancer outcome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02418A true IN2014MN02418A (ja) | 2015-08-14 |
Family
ID=49624503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2418MUN2014 IN2014MN02418A (ja) | 2012-05-22 | 2013-05-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130337444A1 (ja) |
| EP (1) | EP2852689B1 (ja) |
| JP (1) | JP6325530B2 (ja) |
| CN (2) | CN104704128A (ja) |
| AU (1) | AU2013266419B2 (ja) |
| BR (1) | BR112014029300A2 (ja) |
| CA (1) | CA2874492C (ja) |
| ES (1) | ES2763931T3 (ja) |
| IL (1) | IL235795B (ja) |
| IN (1) | IN2014MN02418A (ja) |
| MX (1) | MX369628B (ja) |
| WO (1) | WO2013177245A2 (ja) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2297359T3 (en) | 2008-05-30 | 2014-02-24 | Univ Utah Res Found | Gene expression profiles to predict the outcome of breast cancer |
| US9066963B2 (en) | 2011-03-15 | 2015-06-30 | The University Of North Carolina At Chapel Hill | Methods of treating breast cancer with anthracycline therapy |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| AU2012345789B2 (en) | 2011-11-30 | 2018-02-15 | British Columbia Cancer Agency Branch | Methods of treating breast cancer with taxane therapy |
| JP2016519935A (ja) * | 2013-05-13 | 2016-07-11 | ナノストリング テクノロジーズ，インコーポレイティド | 結節陽性の初期乳癌における再発リスクを予測する方法 |
| DK3013983T3 (da) | 2013-06-25 | 2023-03-06 | Prognosys Biosciences Inc | Spatialt kodede biologiske assays ved brug af en mikrofluidisk anordning |
| CA2923166A1 (en) | 2013-09-09 | 2015-03-12 | British Columbia Cancer Agency Branch | Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy |
| US20160194701A1 (en) | 2014-11-21 | 2016-07-07 | Nanostring Technologies, Inc. | Enzyme- and amplification-free sequencing |
| JP7144142B2 (ja) | 2014-11-24 | 2022-09-29 | ナノストリング テクノロジーズ，インコーポレイティド | 遺伝子精製および画像化のための方法および装置 |
| AU2015359479A1 (en) * | 2014-12-09 | 2017-06-15 | King's College London | Breast cancer treatment with taxane therapy |
| JP6828007B2 (ja) | 2015-04-10 | 2021-02-10 | スペーシャル トランスクリプトミクス アクチボラグ | 生物学的試料の空間識別されるマルチプレックスな核酸分析 |
| WO2017014694A1 (en) * | 2015-07-23 | 2017-01-26 | National University Of Singapore | Wbp2 as a co-prognostic factor with her2 for stratification of patients for treatment |
| CN109715825B (zh) | 2016-05-16 | 2023-01-06 | 纳米线科技公司 | 用于检测样品中目标核酸的方法 |
| US11352667B2 (en) | 2016-06-21 | 2022-06-07 | 10X Genomics, Inc. | Nucleic acid sequencing |
| WO2018074865A2 (ko) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | 유방암 예후 예측용 조성물 및 방법 |
| US10415080B2 (en) | 2016-11-21 | 2019-09-17 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| CN111263819A (zh) | 2017-10-06 | 2020-06-09 | 卡特阿纳公司 | Rna模板化连接 |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| SG11202011274YA (en) | 2018-05-14 | 2020-12-30 | Nanostring Technologies Inc | Chemical compositions and methods of using same |
| EP3877549A1 (en) * | 2018-11-05 | 2021-09-15 | BioNTech Diagnostics GmbH | Predictive methods in breast cancer |
| CN113906147A (zh) | 2019-05-31 | 2022-01-07 | 10X基因组学有限公司 | 检测目标核酸分子的方法 |
| JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
| EP3945136A1 (en) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | In vitro method for the prognosis of patients suffering from her2-positive breast cancer |
| WO2023117807A1 (en) * | 2021-12-20 | 2023-06-29 | Reveal Genomics S.L | Development and validation of an in vitro method for the prognosis of patients suffering from her2-positive breast cancer |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| WO1993006121A1 (en) | 1991-09-18 | 1993-04-01 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| WO1993009668A1 (en) | 1991-11-22 | 1993-05-27 | Affymax Technology N.V. | Combinatorial strategies for polymer synthesis |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| WO1999023254A1 (en) | 1997-10-31 | 1999-05-14 | Affymetrix, Inc. | Expression profiles in adult and fetal organs |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
| DK1641810T4 (en) | 2003-06-24 | 2017-07-03 | Genomic Health Inc | Predicting the likelihood of cancer recurrence |
| AU2004285103A1 (en) * | 2003-09-29 | 2005-05-12 | Pathwork Diagnostics, Inc. | Systems and methods for detecting biological features |
| CA2574447A1 (en) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Housekeeping genes and methods for identifying the same |
| CN101057144A (zh) * | 2004-09-22 | 2007-10-17 | 三路影像公司 | 用于评价乳腺癌预后的方法和组合物 |
| US20090299640A1 (en) | 2005-11-23 | 2009-12-03 | University Of Utah Research Foundation | Methods and Compositions Involving Intrinsic Genes |
| JP5537034B2 (ja) * | 2005-12-23 | 2014-07-02 | ナノストリング テクノロジーズ，インコーポレーテッド | ナノレポーターならびにその作製方法および使用方法 |
| WO2007076132A2 (en) | 2005-12-23 | 2007-07-05 | Nanostring Technologies, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
| EP2155899A2 (en) | 2007-04-10 | 2010-02-24 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
| JP2010538609A (ja) * | 2007-09-06 | 2010-12-16 | バイオセラノスティクス，インコーポレイティド | 腫瘍グレード分類と癌の予後診断 |
| DK2297359T3 (en) * | 2008-05-30 | 2014-02-24 | Univ Utah Res Found | Gene expression profiles to predict the outcome of breast cancer |
| CA2733609C (en) | 2008-08-14 | 2018-03-06 | Nanostring Technologies, Inc. | Stable nanoreporters |
| JP5940517B2 (ja) * | 2010-03-31 | 2016-06-29 | ジヴィドン ダイアグノスティックス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 内分泌治療下における乳癌再発を予測するための方法 |
-
2013
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 CA CA2874492A patent/CA2874492C/en active Active
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/en active Application Filing
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/en active Active
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2852689A2 (en) | 2015-04-01 |
| CN111500718A (zh) | 2020-08-07 |
| JP6325530B2 (ja) | 2018-05-16 |
| IL235795B (en) | 2020-02-27 |
| AU2013266419B2 (en) | 2018-09-27 |
| US20200332368A1 (en) | 2020-10-22 |
| CA2874492C (en) | 2021-10-19 |
| EP2852689A4 (en) | 2016-05-11 |
| ES2763931T3 (es) | 2020-06-01 |
| WO2013177245A3 (en) | 2015-01-29 |
| CA2874492A1 (en) | 2013-11-28 |
| IL235795A0 (en) | 2015-01-29 |
| WO2013177245A2 (en) | 2013-11-28 |
| JP2015518724A (ja) | 2015-07-06 |
| CN104704128A (zh) | 2015-06-10 |
| MX369628B (es) | 2019-11-14 |
| US20230272476A1 (en) | 2023-08-31 |
| US20130337444A1 (en) | 2013-12-19 |
| BR112014029300A2 (pt) | 2017-07-25 |
| EP2852689B1 (en) | 2019-12-11 |
| AU2013266419A1 (en) | 2014-12-11 |
| MX2014014275A (es) | 2015-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02418A (ja) | ||
| CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
| MX2019007814A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
| MX2014006404A (es) | Metodos y kits para el pronostico del cancer colorrectal. | |
| EA201370063A1 (ru) | Фосфолипидом рака | |
| NZ599194A (en) | Methods to predict clinical outcome of cancer | |
| WO2015052583A3 (en) | Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer | |
| MX357429B (es) | Predictores para el tratamiento del cáncer. | |
| WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
| PH12014502410A1 (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| NZ621638A (en) | Dna methylation in colorectal and breast cancer diagnostic methods | |
| WO2011153545A3 (en) | Gene expression signature as a predictor of chemotherapeutic response in breast cancer | |
| WO2014184679A3 (en) | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
| MX2013008252A (es) | Firma de pronostico para la recurrencia de cancer colorrectal. | |
| BR112015022977A2 (pt) | métodos para predição de risco de metástase em melanoma cutâneo | |
| Montserrat et al. | Present and future of personalized medicine in CLL | |
| IN2014DN08312A (ja) | ||
| RU2010149541A (ru) | Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением | |
| RU2012140862A (ru) | Способ прогнозирования риска возникновения переломов | |
| Cui et al. | DIFFERENTIALLY EXPRESSED MIRNAS AND THEIR SURVIVAL PREDICTION IN THE HIGH GRADE SEROUS AND CLEAR CELL OVARIAN CARCINOMA: IGCS-0043 06. Ovarian Cancer | |
| UA108260U (uk) | Спосіб прогнозування розвитку остеопорозу | |
| WO2011133500A3 (en) | Detection and analysis of epigenetic and genetic changes in tumor tissue | |
| UA95616U (uk) | Спосіб прогнозування зрощення перелому | |
| Salmoiraghi et al. | Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients | |
| Brennan | Quantifying Biomarker Risks and Benefits |